mRNA-based COVID-19 booster vaccination is highly effective and cost-effective in Australia
View ORCID ProfileRui Li, Hanting Liu, Christopher K Fairley, Jason J Ong, Yuming Guo, Zhuoru Zou, Li Xie, Guihua Zhuang, Yan Li, View ORCID ProfileMingwang Shen, View ORCID ProfileLei Zhang
doi: https://doi.org/10.1101/2022.05.08.22274797
Rui Li
1China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi, 710061, China
Hanting Liu
1China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi, 710061, China
Christopher K Fairley
1China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi, 710061, China
2Melbourne Sexual Health Centre, Alfred Health, Melbourne, Australia
3Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia
Jason J Ong
1China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi, 710061, China
2Melbourne Sexual Health Centre, Alfred Health, Melbourne, Australia
3Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia
Yuming Guo
1China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi, 710061, China
2Melbourne Sexual Health Centre, Alfred Health, Melbourne, Australia
3Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia
Zhuoru Zou
1China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi, 710061, China
Li Xie
1China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi, 710061, China
Guihua Zhuang
1China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi, 710061, China
5Key Laboratory for Disease Prevention and Control and Health Promotion of Shaanxi Province, Xi’an, Shaanxi, 710061, China
Yan Li
6Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA
7Department of Obstetrics, Gynaecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Mingwang Shen
1China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi, 710061, China
5Key Laboratory for Disease Prevention and Control and Health Promotion of Shaanxi Province, Xi’an, Shaanxi, 710061, China
Lei Zhang
1China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi, 710061, China
2Melbourne Sexual Health Centre, Alfred Health, Melbourne, Australia
3Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia
4Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou 450001, Henan, China
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data produced in the present work are contained in the manuscript
Posted May 10, 2022.
mRNA-based COVID-19 booster vaccination is highly effective and cost-effective in Australia
Rui Li, Hanting Liu, Christopher K Fairley, Jason J Ong, Yuming Guo, Zhuoru Zou, Li Xie, Guihua Zhuang, Yan Li, Mingwang Shen, Lei Zhang
medRxiv 2022.05.08.22274797; doi: https://doi.org/10.1101/2022.05.08.22274797
mRNA-based COVID-19 booster vaccination is highly effective and cost-effective in Australia
Rui Li, Hanting Liu, Christopher K Fairley, Jason J Ong, Yuming Guo, Zhuoru Zou, Li Xie, Guihua Zhuang, Yan Li, Mingwang Shen, Lei Zhang
medRxiv 2022.05.08.22274797; doi: https://doi.org/10.1101/2022.05.08.22274797
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (671)
- Anesthesia (181)
- Cardiovascular Medicine (2657)
- Dermatology (224)
- Emergency Medicine (401)
- Epidemiology (12255)
- Forensic Medicine (10)
- Gastroenterology (765)
- Genetic and Genomic Medicine (4117)
- Geriatric Medicine (387)
- Health Economics (681)
- Health Informatics (2666)
- Health Policy (1007)
- Hematology (364)
- HIV/AIDS (854)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (440)
- Neurology (3899)
- Nursing (210)
- Nutrition (579)
- Oncology (2041)
- Ophthalmology (586)
- Orthopedics (242)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (452)
- Public and Global Health (6542)
- Radiology and Imaging (1407)
- Respiratory Medicine (871)
- Rheumatology (411)
- Sports Medicine (343)
- Surgery (452)
- Toxicology (54)
- Transplantation (185)
- Urology (167)